NCT05011058 · Interventional trial
An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas
Overall registry status Terminated
Phase 2
Conditions EBV Related PTCL, NOS, EBV-Positive DLBCL, NOS, EBV-Related Hodgkin Lymphoma, EBV-Related Lymphoproliferative Disorder, EBV-Related Non-Hodgkin Lymphoma, EBV-Related PTLD, Epstein-Barr Virus Associated Lymphoma
Delaware Valley sites
- Sidney Kimmel Cancer Center - Jefferson Health · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory